HighTower Advisors
MIST icon

HighTower Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

HighTower Advisors’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9K Buy
+10,000
New +$17.5K ﹤0.01% 3780
2023
Q3 		– Sell
-31,000
Closed -$88K – 3688
2023
Q2 		$88K Buy
31,000
+4,800
+18% +$18.1K ﹤0.01% 3094
2023
Q1 		$103K Buy
+26,200
New +$95.8K ﹤0.01% 2941

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

HighTower Advisors's MIST Position: Q1 2026 in Review

HighTower Advisors opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 10,000 shares worth $11.9K. The stake represents ﹤0.01% of the portfolio and ranks #3780 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in MIST as recently as Q2 2023.

HighTower Advisors first reported a position in MIST in Q1 2023 and has held it in 3 quarters since. The position peaked at $103K in Q1 2023. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • HighTower Advisors held 10,000 shares of Milestone Pharmaceuticals worth $11.9K as of Q1 2026.
  • Milestone Pharmaceuticals was a new HighTower Advisors position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3780 holding.
  • HighTower Advisors first reported a position in Milestone Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • HighTower Advisors's Milestone Pharmaceuticals position peaked at $103K in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.